Skip to main content
  • Saved

Commented on 's Post

Amgen Launches Biomarker Assist™, a Program To Help More Patients With Non-Small Cell Lung Cancer Gain Access To Biomarker Testing

Amgen Launches Biomarker Assist™, a Program To Help More Patients With Non-Small Cell Lung Cancer Gain Access To Biomarker Testing

Source :

https://www.prnewswire.com/news-releases/amgen-launches-biomarker-assist-a-program-to-help-more-patients-with-non-small-cell-lung-cancer-gain-access-to-biomarker-testing-301270896.html

THOUSAND OAKS, Calif., April 19, 2021 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced the launch of Biomarker Assist™ , a program to help more patients with metastatic (stage IV) non-small cell lung cancer (NSCLC) gain access to biomarker testing. Biomarker testing at the time of diagnosis is a critical first step in getting patients on the right treatment.

  • 2 days 2 hours
    What are your perceptions of patient access to biomarker testing? Please share.